These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18420211)

  • 21. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome, inflammation and atherothrombosis.
    Rohla M; Weiss TW
    Hamostaseologie; 2013; 33(4):283-94. PubMed ID: 23979637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.
    Picardi A; Vespasiani-Gentilucci U
    Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammation, the metabolic syndrome and cardiovascular risk.
    Tracy RP
    Int J Clin Pract Suppl; 2003 Mar; (134):10-7. PubMed ID: 12793593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome.
    Izar MC; Fonseca HA; Pinheiro LF; Monteiro CM; Póvoa RM; Monteiro AM; Figueiredo-Neto AM; Gidlund MA; Fonseca FA
    Diab Vasc Dis Res; 2013 Jan; 10(1):32-9. PubMed ID: 22529217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin loading for acute coronary syndromes.
    Nusca A; Melfi R; Patti G; Di Sciascio G
    Curr Opin Cardiol; 2010 Jul; 25(4):373-8. PubMed ID: 20520540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
    Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
    Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk.
    Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A
    Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the metabolic syndrome on high-sensitivity C reactive protein levels in patients with acute coronary syndrome.
    Kilic T; Jneid H; Ural E; Oner G; Sahin T; Kozdag G; Kahraman G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):591-6. PubMed ID: 19577754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory markers in coronary artery disease.
    Ikonomidis I; Michalakeas CA; Parissis J; Paraskevaidis I; Ntai K; Papadakis I; Anastasiou-Nana M; Lekakis J
    Biofactors; 2012; 38(5):320-8. PubMed ID: 22628054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of non-lipid risk factors: a review focusing on C-reactive protein].
    Yilmaz Y; Ongen Z
    Turk Kardiyol Dern Ars; 2009 Apr; 37 Suppl 4():7-13. PubMed ID: 19553756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inflammation in acute coronary syndromes: mechanisms and clinical implications].
    Angiolillo DJ; Biasucci LM; Liuzzo G; Crea F
    Rev Esp Cardiol; 2004 May; 57(5):433-46. PubMed ID: 15151777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers, C-reactive proteins and statins in acute coronary syndromes.
    Ray KK
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():31-3. PubMed ID: 18001319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-alcoholic fatty liver disease: a new challenge for cardiologists].
    Tarquini R; Lazzeri C; Boddi M; Marra F; Abbate R; Gensini GF
    G Ital Cardiol (Rome); 2010 Sep; 11(9):660-9. PubMed ID: 21348181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome, inflammation and atherosclerosis - the role of adipokines in health and in systemic inflammatory rheumatic diseases.
    Santos MJ; Fonseca JE
    Acta Reumatol Port; 2009; 34(4):590-8. PubMed ID: 20852572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part I].
    Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
    Przegl Lek; 2006; 63(9):762-6. PubMed ID: 17479866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRP and the risk of atherosclerotic events.
    Calabrò P; Golia E; Yeh ET
    Semin Immunopathol; 2009 Jun; 31(1):79-94. PubMed ID: 19415283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins.
    Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C
    Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.